Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00168168
Status:
COMPLETED
Last Update Posted:
2010-02-09
First Post:
2005-09-14
Brief Title:
ACB A Randomized Study of 25ugkgDay vs 5ugkgDay Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem CellMarrow Transplant Recipients FILE17159
Sponsor:
Alberta Health services
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
ACB A Randomized Study of 25ugkgDay vs 5ugkgDay Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem CellMarrow Transplant Recipients FILE17159
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate recovery time on 25 mgKgday dose of G-CSF versus 5 mgKgday dose
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None